logo
AI Icon𝛼SK or Search
ENTITY

Canbas Co Ltd (4575 JP)

7
Analysis
Health Care • Japan
CanBas Company Ltd. is a biopharmaceutical company that develops anti-cancer drugs with fewer side effects. The Company's core technologies include drugs that target the G2 checkpoint and a screening system to find selective abrogators of the G2 checkpoint.
more
bullish•Canbas Co Ltd
•14 Feb 2025 10:00•Issuer-paid

Canbas Co Ltd (4575 JP): 1H FY06/25 flash update

CanBas reported no operating revenue and a net loss of JPY480mn, with R&D expenses increasing by 33.9% YoY. Total assets rose by JPY699mn due...

Logo
Shared Research
438 Views
Share
bullish•Canbas Co Ltd
•14 Nov 2024 17:00•Issuer-paid

Canbas Co Ltd (4575 JP): Q1 FY06/25 flash update

CanBas reported no operating revenue in Q1 FY06/24, with an operating loss of JPY251mn and increased R&D expenses. Total assets rose by...

Logo
Shared Research
379 Views
Share

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x